Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.
Gordon H, Biancone L, Fiorino G, Katsanos KH, Kopylov U, Al Sulais E, Axelrad JE, Balendran K, Burisch J, de Ridder L, Derikx L, Ellul P, Greuter T, Iacucci M, Di Jiang C, Kapizioni C, Karmiris K, Kirchgesner J, Laharie D, Lobatón T, Molnár T, Noor NM, Rao R, Saibeni S, Scharl M, Vavricka SR, Raine T. Gordon H, et al. Among authors: laharie d. J Crohns Colitis. 2023 Jun 16;17(6):827-854. doi: 10.1093/ecco-jcc/jjac187. J Crohns Colitis. 2023. PMID: 36528797 Free article. No abstract available.
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study.
Martin A, Nachury M, Peyrin-Biroulet L, Bouhnik Y, Nancey S, Bourrier A, Serrero M, Fumery M, Buisson A, Laharie D, Gilletta C, Filippi J, Allez M, Bouguen G, Roblin X, Altwegg R, Dib N, Pineton de Chambrun G, Savoye G, Carbonnel F, Viennot S, Amiot A; GETAID-Vedo-STOP Study Group. Martin A, et al. Among authors: laharie d. J Crohns Colitis. 2020 Jul 30;14(7):896-903. doi: 10.1093/ecco-jcc/jjaa005. J Crohns Colitis. 2020. PMID: 31930285 Free article.
A Rare Cause of Colonic Obstruction in Inflammatory Bowel Disease.
Le Cosquer G, Célérier B, Laharie D. Le Cosquer G, et al. Among authors: laharie d. Am J Gastroenterol. 2023 Jun 1;118(6):926. doi: 10.14309/ajg.0000000000002116. Epub 2022 Dec 23. Am J Gastroenterol. 2023. PMID: 36689732 No abstract available.
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.
Bacha RA, Bouhnik Y, Serrero M, Filippi J, Roblin X, Bourrier A, Bouguen G, Franchimont D, Savoye G, Buisson A, Louis E, Nancey S, Abitbol V, Reimund JM, DeWit O, Vuitton L, Mathieu N, Peyrin-Biroulet L, Gilletta C, Allez M, Viennot S, Berre CL, Laharie D, Nachury M, Amiot A; GETAID-patient experience study group. Bacha RA, et al. Among authors: laharie d. Dig Liver Dis. 2023 Dec;55(12):1632-1639. doi: 10.1016/j.dld.2023.05.008. Epub 2023 May 26. Dig Liver Dis. 2023. PMID: 37246095 Free article.
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.
Amiot A, Bourrier A, Gornet JM, Dewit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Gagnière C, Buisson A, Nachury M, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Seksik P; GETAID-INFOPRO study group. Amiot A, et al. Among authors: laharie d. Infect Prev Pract. 2023 Mar;5(1):100267. doi: 10.1016/j.infpip.2022.100267. Epub 2022 Dec 30. Infect Prev Pract. 2023. PMID: 36601289 Free PMC article.
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E; GETAID and the SPARE-Biocycle research group. Louis E, et al. Among authors: laharie d, d haens g. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):215-227. doi: 10.1016/S2468-1253(22)00385-5. Epub 2023 Jan 11. Lancet Gastroenterol Hepatol. 2023. PMID: 36640794 Free PMC article. Clinical Trial.
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
Rayer C, Nachury M, Bourreille A, Roblin X, Peyrin-Biroulet L, Viennot S, Flamant M, Laharie D, Caron B, Dewitte M, Siproudhis L, Fumery M, Bouguen G. Rayer C, et al. Among authors: laharie d. BMC Gastroenterol. 2023 Feb 2;23(1):31. doi: 10.1186/s12876-022-02636-9. BMC Gastroenterol. 2023. PMID: 36732693 Free PMC article. No abstract available.
Long-term outcome of risankizumab in Crohn's disease: a real-world GETAID study.
Fumery M, Caron B, Hébuterne X, Altwegg R, Roblin X, Stefanescu C, Meyer A, Nachury M, Laharie D, Le Berre C, Guillo L, Biron A, Caillo L, Buisson A, Nancey S, Uzzan M, Vuitton L, Gilletta C, Geyl S, Blain A, Kirchgesner J, Ah-Soune P, Duveau N, Vidon M, Abitbol V, Paupard T, Tran-Minh ML, Defrance A, Peyrin-Biroulet L. Fumery M, et al. Among authors: laharie d. Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00423-3. doi: 10.1016/j.cgh.2024.04.016. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38729389
239 results